Atlas Trials

Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery

Clinical trial NCT01292083 · WITHDRAWN

Trial details

NCT number
NCT01292083
Sponsor
University of Southern California
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Recurrent Breast CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast CancerTriple-negative Breast Cancer
Start date
2011-01-01
Primary completion
2013-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.